Jesper Larsen

Dr. Jesper Larsen

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
NMNatasha Madsen
Natasha Madsen
BNBoye Schnack Nielsen
Boye Schnack Nielsen
SNSon Ly Nhat
Son Ly Nhat
Søren SkovSøren Skov
Søren Skov
MGMonika Gad
Monika Gad
JLJesper Larsen
Jesper Larsen
Tumor-associated macrophages often correlate with tumor progression, and therapies targeting immune cells in tumors have emerged as promising treatments. To select effective therapies, we established an in vitro 3D multicellular spheroid model including cancer cells, fibroblasts, and monocytes. We analyzed monocyte infiltration and differentiation in spheroids generated from fibroblasts and either of the cancer cell lines MCF-7, HT-29, PANC-1, or MIA PaCa-2. Monocytes rapidly infiltrated spheroids and differentiated into mature macrophages with diverse phenotypes in a cancer cell line-dependent manner. MIA PaCa-2 spheroids polarized infiltrating monocytes to M2-like macrophages with high CD206 and CD14 expression, whereas monocytes polarized by MCF-7 spheroids displayed an M1-like phenotype. Monocytes in HT-29 and PANC-1 primarily obtained an M2-like phenotype but also showed upregulation of M1 markers. Analysis of the secretion of 43 soluble factors demonstrated that the cytokine profile between spheroid cultures differed considerably depending on the cancer cell line. Secretion of most of the cytokines increased upon the addition of monocytes resulting in a more inflammatory and pro-tumorigenic environment. These multicellular spheroids can be used to recapitulate the tumor microenvironment and the phenotype of tumor-associated macrophages in vitro and provide more realistic 3D cancer models allowing the in vitro screening of immunotherapeutic compounds.

1 January 2016 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
SBSusanne W. Bruun
Susanne W. Bruun
KJKnud Elnegaard Josefsen
Knud Elnegaard Josefsen
JTJulia T. Tanassi
Julia T. Tanassi
AMAleš Marek
Aleš Marek
MPMartin H. F. Pedersen
Martin H. F. Pedersen
KBKarsten Buschard
Karsten Buschard
Gluten promotes type 1 diabetes in nonobese diabetic (NOD) mice and likely also in humans. In NOD mice and in non-diabetes-prone mice, it induces inflammation in the pancreatic lymph nodes, suggesting that gluten can initiate inflammation locally. Further, gliadin fragments stimulate insulin secretion from beta cells directly. We hypothesized that gluten fragments may cross the intestinal barrier to be distributed to organs other than the gut. If present in pancreas, gliadin could interact directly with the immune system and the beta cells to initiate diabetes development. We orally and intravenously administered 33-mer and 19-mer gliadin peptide to NOD, BALB/c, and C57BL/6 mice and found that the peptides readily crossed the intestinal barrier in all strains. Several degradation products were found in the pancreas by mass spectroscopy. Notably, the exocrine pancreas incorporated large amounts of radioactive label shortly after administration of the peptides. The study demonstrates that, even in normal animals, large gliadin fragments can reach the pancreas. If applicable to humans, the increased gut permeability in prediabetes and type 1 diabetes patients could expose beta cells directly to gliadin fragments. Here they could initiate inflammation and induce beta cell stress and thus contribute to the development of type 1 diabetes.

1 February 2021 in International Immunopharmacology
Verified
Journal Article
Closed access
CMCaroline B.K. Mathiesen
Caroline B.K. Mathiesen
ARAsha M. Rudjord-Levann
Asha M. Rudjord-Levann
MGMonika Gad
Monika Gad
JLJesper Larsen
Jesper Larsen
FSFinn Sellebjerg
Finn Sellebjerg
APAnders Elm Pedersen
Anders Elm Pedersen

26 October 2020 in Stem Cells International
Verified
Journal Article
Open access
PDF file
MJMorten Juhl
Morten Juhl
Bjarke FollinBjarke Follin
Bjarke Follin
MGMonika Gad
Monika Gad
JLJesper Larsen
Jesper Larsen
JKJens Kastrup
Jens Kastrup
AEAnnette Ekblond
Annette Ekblond
Allogeneic cell-based therapies using adipose tissue-derived stromal cells (ASCs) offer an off-the-shelf alternative to autologous therapy. An underlying assumption is that ASC can modulate the immune response of the recipient. However, in vitro models are required to explore and identify cell interactions and mechanisms of action, to ensure sufficient and sustained effects, and to document these. In this study, we shed light on the effect of ASC manufactured for clinical use on monocyte-derived dendritic cells and an inflammatory microenvironment. ASCs were isolated from healthy voluntary donors, expanded using a human platelet lysate in bioreactors, and cryopreserved as per clinical use. Monocyte-derived dendritic cells were generated by isolation of monocytes and differentiation with GM-CSF and IL-4. Dendritic cells were cocultured with different ratios of ASC and matured with LPS and IFN-γ. Dexamethasone was included as an immunosuppressive control. Dendritic cells were analyzed by flow cytometry for CD11c, CD40, CD80, CD83, CD86, PD-L1, and HLA-DR, and supernatants were analyzed for FGF2, HGF, IL-10, IL-12p70, LIF, MIF, PDGF, PlGF, and IDO. Reduced expression of maturation markers was observed on ASC-treated dendritic cells, while high levels of PD-L1 were maintained. Interestingly, the expression of CD83 was elevated. Escalating ratios of ASC did not affect the concentration of IL-10 considerably, whereas the presence of IL-12 was reduced in a dose-dependent manner. Besides offsetting the IL-12/IL-10 balance, the concentrations of IDO and MIF were elevated in cocultures. Concentrations of FGF2, HGF, LIF, and PIGF were high in ASC cocultures, whereas PDGF was depleted. In a robust coculture model, the addition of ASC to dendritic cells inhibited the dendritic maturation substantially, while inducing a less inflammatory and more tolerogenic milieu. Despite the exposure to dendritic cells and inflammatory stimuli, ASC resulted in supernatants with trophic factors relevant for regeneration. Thus, ASC can perform immunomodulation while providing a regenerative environment.

2 February 2022 in Journal of Immunological Methods
Verified
Journal Article
Closed access
NMNatasha Helleberg Madsen
Natasha Helleberg Madsen
MGMonika Gad
Monika Gad
JLJesper Larsen
Jesper Larsen

12 March 2017 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
SBSusanne W. Bruun
Susanne W. Bruun
KJKnud Elnegaard Josefsen
Knud Elnegaard Josefsen
JTJulia T. Tanassi
Julia T. Tanassi
AMAleš Marek
Aleš Marek
MPMartin H. F. Pedersen
Martin H. F. Pedersen
KBKarsten Buschard
Karsten Buschard
[This corrects the article DOI: 10.1155/2016/2424306.].